Imagion Biosystems has announced “Notice of Annual General Meeting/Proxy Form.”
Click here to view the notice (726 KB pdf)
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal